These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30134146)

  • 21. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
    Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
    EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic targeting of BET protein BRD4 delays murine lupus.
    Wei S; Sun Y; Sha H
    Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
    Khan YM; Kirkham P; Barnes PJ; Adcock IM
    PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice.
    Lee DU; Katavolos P; Palanisamy G; Katewa A; Sioson C; Corpuz J; Pang J; DeMent K; Choo E; Ghilardi N; Diaz D; Danilenko DM
    Toxicol Appl Pharmacol; 2016 Jun; 300():47-54. PubMed ID: 27078884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair.
    Gaudet AD; Mandrekar-Colucci S; Hall JC; Sweet DR; Schmitt PJ; Xu X; Guan Z; Mo X; Guerau-de-Arellano M; Popovich PG
    J Neurosci; 2016 Aug; 36(32):8516-32. PubMed ID: 27511021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.
    Horne GA; Stewart HJ; Dickson J; Knapp S; Ramsahoye B; Chevassut T
    Stem Cells Dev; 2015 Apr; 24(7):879-91. PubMed ID: 25393219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of inflammatory genes in decidual cells: Involvement of the bromodomain and extra-terminal family proteins.
    Ajgaonkar S; Hirst JJ; Norris M; Zakar T
    PLoS One; 2023; 18(3):e0280645. PubMed ID: 36897880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve Excitability and Neuropathic Pain is Reduced by BET Protein Inhibition After Spared Nerve Injury.
    Palomés-Borrajo G; Badia J; Navarro X; Penas C
    J Pain; 2021 Dec; 22(12):1617-1630. PubMed ID: 34157407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
    Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.
    Antolic A; Wakimoto H; Jiao Z; Gorham JM; DePalma SR; Lemieux ME; Conner DA; Lee DY; Qi J; Seidman JG; Bradner JE; Brown JD; Haldar SM; Seidman CE; Burke MA
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32603312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke.
    DeMars KM; Yang C; Candelario-Jalil E
    Neurochem Int; 2019 Jul; 127():94-102. PubMed ID: 30872008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function.
    Cribbs AP; Filippakopoulos P; Philpott M; Wells G; Penn H; Oerum H; Valge-Archer V; Feldmann M; Oppermann U
    Front Immunol; 2021; 12():626255. PubMed ID: 33717143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.
    Borck PC; Guo LW; Plutzky J
    Circ Res; 2020 Apr; 126(9):1190-1208. PubMed ID: 32324495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
    Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
    J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
    Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment.
    Hu J; Yang Z; Li X; Lu H
    J Neuroinflammation; 2016 Jun; 13(1):162. PubMed ID: 27334337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration.
    Zhao L; Li J; Fu Y; Zhang M; Wang B; Ouellette J; Shahi PK; Pattnaik BR; Watters JJ; Wong WT; Guo LW
    J Neuroinflammation; 2017 Jan; 14(1):14. PubMed ID: 28103888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.
    Wienerroither S; Rauch I; Rosebrock F; Jamieson AM; Bradner J; Muhar M; Zuber J; Müller M; Decker T
    Mol Cell Biol; 2014 Feb; 34(3):415-27. PubMed ID: 24248598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.
    Bevill SM; Olivares-Quintero JF; Sciaky N; Golitz BT; Singh D; Beltran AS; Rashid NU; Stuhlmiller TJ; Hale A; Moorman NJ; Santos CM; Angus SP; Zawistowski JS; Johnson GL
    Mol Cancer Res; 2019 Jul; 17(7):1503-1518. PubMed ID: 31000582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.